Professional Documents
Culture Documents
pharmaceutical industry
– The Novo Nordisk Way…..
Industry challenges:
Innovation, cost and trust
NATIONAL HUMAN
CLIMATE
RIGHTS
CHANGE ACCESS MARKET LEVEL EDUCATION
PRICING TO CARE
SCHEMES AWARENESS
PRODUCT PATIENT PRODUCT
QUALITY LEVEL SAFETY
DAWN OPTIMAL
CUSTOMER CUSTOMER
PUBLIC CONTROL
INNOVATION SATISFACTION SOCIO-
HEALTH STRATEGY ECONOMICS
ADDITIONAL
INFRA- NATIONAL
FUNDING
STRUCTURE CHANGING DIABETES
BUSINESS PROGRAMMES ACCESS TO
ETHICS HEALTH
ACCOUNTABLE RESPONSIBLE
PARTNERSHIPS LOBBYING
DIVERSITY
Dialogue and Action Page 8
The precautionary
principle assumes that
there is a risk, when we
cannot prove if the risk is
real
Dialogue and Action Page 9
~
280,000 t
With cLEAN®
Without CO2 strategy
350,000 t
With cLEAN®
>158,000 t
With CO2 strategy
• Innovation
• Employee engagement